Skip to main content
Erschienen in: Acta Diabetologica 6/2012

01.12.2012 | Original Article

Association of the apolipoprotein B/apolipoprotein A-I ratio and low-density lipoprotein cholesterol with insulin resistance in a Chinese population with abdominal obesity

verfasst von: Xin Ying, Yafang Qian, Yan Jiang, Zhenyan Jiang, Zhenya Song, Changjun Zhao

Erschienen in: Acta Diabetologica | Ausgabe 6/2012

Einloggen, um Zugang zu erhalten

Abstract

The aim of this study is to assess the relationships among the apolipoprotein B/apolipoprotein A-I ratio (apoB/apoA-I ratio), low-density lipoprotein cholesterol (LDL-C) and insulin resistance (IR) in a Chinese population with abdominal obesity. This is a population-based, cross-sectional study of 3,945 men and 2,141 women with abdominal obesity. Individuals were referred to a primary health service and recruited for analysis. IR was measured using a homeostasis model assessment of insulin resistance (HOMA2-IR) with a HOMA2 calculator. Metabolic syndrome (MetS) was diagnosed using International Diabetes Federation (IDF) criteria. Comparing the apoB/apoA-I ratio and lipid indices using the HOMA2-IR showed that the ratio, LDL-C, total cholesterol level (TC) and triglyceride level (TG) were higher; and the high-density lipoprotein cholesterol level (HDL-C) was lower in the fourth than in the first quartile in both sexes (p ≤ 0.001). After adjustment for age, HOMA2-IR was positively correlated with the apoB/apoA-I ratio, LDL-C, TC and TG; and negatively correlated with HDL-C in men (all p < 0.0001). HOMA2-IR was also positively correlated with the apoB/apoA-I ratio, LDL-C, TC and TG; and negatively correlated with HDL-C in women (all p < 0.01). After adjustment for age and LDL-C, HOMA2-IR was found to be correlated with the apoB/apoA-I ratio in both men and women (r = 0.066 and 0.116, p < 0.0001). After adjustment for age and the apoB/apoA-I ratio, HOMA2-IR was correlated with LDL-C in men and women (r = 0.063 and 0.044, p < 0.0001 and p = 0.0431, respectively). Gender, age, LDL-C, BMI, HOMA2-IR and apoB/apoA-I were the covariates independently associated with presence of the MetS (Odds ratio, OR: 2.183, 1.034, 1.013, 1.157, 1.726 and 1.570, respectively; all p < 0.05). In conclusion, the study showed that the apoB/apoA-I ratio and LDL-C were positively correlated with IR. Excluding reciprocal interactions, the apoB/apoA-I ratio and LDL-C were still significantly correlated with IR, but the apoB/apoA-I ratio showed a greater correlation with IR than LDL-C in women with abdominal obesity, compared with men with abdominal obesity. Both LDL-C and apoB/apoA-I were independent risk factors of MetS, and the apoB/apoA-I ratio was stronger in this regard than LDL-C for this obese population.
Literatur
1.
Zurück zum Zitat Hu G, Qiao Q, Tuomilehto J et al (2004) Plasma insulin and cardiovascular mortality in non-diabetic European men and women: a meta-analysis of data from eleven prospective studies. Diabetologia 47:1245–1256PubMed Hu G, Qiao Q, Tuomilehto J et al (2004) Plasma insulin and cardiovascular mortality in non-diabetic European men and women: a meta-analysis of data from eleven prospective studies. Diabetologia 47:1245–1256PubMed
2.
Zurück zum Zitat Choi K, Kim YB (2010) Molecular mechanism of insulin resistance in obesity and type 2 diabetes. Korean J Intern Med 25:119–129PubMedCrossRef Choi K, Kim YB (2010) Molecular mechanism of insulin resistance in obesity and type 2 diabetes. Korean J Intern Med 25:119–129PubMedCrossRef
3.
Zurück zum Zitat Balkau B, Charles MA, Drivsholm T et al (2002) Frequency of the WHO metabolic syndrome in European cohorts, and an alternative definition of an insulin resistance syndrome. Diabetes Metab 28:364–376PubMed Balkau B, Charles MA, Drivsholm T et al (2002) Frequency of the WHO metabolic syndrome in European cohorts, and an alternative definition of an insulin resistance syndrome. Diabetes Metab 28:364–376PubMed
4.
Zurück zum Zitat Alberti KG, Zimmet P, Shaw J et al (2005) The metabolic syndrome: a new world wide definition. Lancet 366:1059–1062PubMedCrossRef Alberti KG, Zimmet P, Shaw J et al (2005) The metabolic syndrome: a new world wide definition. Lancet 366:1059–1062PubMedCrossRef
5.
Zurück zum Zitat Howard BV, Robbins DC, Sievers ML et al (2000) LDL cholesterol as a strong predictor of coronary heart disease in diabetic individuals with insulin resistance and low LDL: the strong heart study. Arterioscler Thromb Vasc Biol 20:830–835PubMedCrossRef Howard BV, Robbins DC, Sievers ML et al (2000) LDL cholesterol as a strong predictor of coronary heart disease in diabetic individuals with insulin resistance and low LDL: the strong heart study. Arterioscler Thromb Vasc Biol 20:830–835PubMedCrossRef
6.
Zurück zum Zitat Wallenfeldt K, Bokemark L, Wikstrand J et al (2004) Apolipoprotein B/apolipoprotein A-I in relation to the metabolic syndrome and change in carotid artery intima-media thickness during 3 years in middle-aged men. Stroke 35:2248–2252PubMedCrossRef Wallenfeldt K, Bokemark L, Wikstrand J et al (2004) Apolipoprotein B/apolipoprotein A-I in relation to the metabolic syndrome and change in carotid artery intima-media thickness during 3 years in middle-aged men. Stroke 35:2248–2252PubMedCrossRef
7.
Zurück zum Zitat Dahlén EM, Länne T, Engvall J et al (2009) Carotid intima-media thickness and apolipoprotein B/apolipoprotein A-I ratio in middle-aged patients with Type 2 diabetes. Diabet Med 26:384–390PubMedCrossRef Dahlén EM, Länne T, Engvall J et al (2009) Carotid intima-media thickness and apolipoprotein B/apolipoprotein A-I ratio in middle-aged patients with Type 2 diabetes. Diabet Med 26:384–390PubMedCrossRef
8.
Zurück zum Zitat Sierra-Johnson J, Romero-Corral A, Somers VK et al (2007) ApoB/apoA-I ratio: an independent predictor of insulin resistance in US non-diabetic subjects. Eur Heart J 28:2637–2643PubMedCrossRef Sierra-Johnson J, Romero-Corral A, Somers VK et al (2007) ApoB/apoA-I ratio: an independent predictor of insulin resistance in US non-diabetic subjects. Eur Heart J 28:2637–2643PubMedCrossRef
9.
Zurück zum Zitat Onat A, Hergenc G, Sari I et al (2007) Elevated LDL-cholesterol level predicts diabetes in centrally obese women but not men: relative roles of insulin resistance and central obesity. Circ J 71:1463–1467PubMedCrossRef Onat A, Hergenc G, Sari I et al (2007) Elevated LDL-cholesterol level predicts diabetes in centrally obese women but not men: relative roles of insulin resistance and central obesity. Circ J 71:1463–1467PubMedCrossRef
10.
Zurück zum Zitat Walldius G, Jungner I (2006) The apoB/apoA-I ratio: a strong, new risk factor for cardiovascular disease and a target for lipid-lowering therapy–a review of the evidence. J Intern Med 259:493–519PubMedCrossRef Walldius G, Jungner I (2006) The apoB/apoA-I ratio: a strong, new risk factor for cardiovascular disease and a target for lipid-lowering therapy–a review of the evidence. J Intern Med 259:493–519PubMedCrossRef
11.
Zurück zum Zitat Alberti KG, Zimmet P, Shaw J (2006) Metabolic syndrome: a new world-wide definition. A consensus statement from the International Diabetes Federation. Diabet Med 23:469–480PubMedCrossRef Alberti KG, Zimmet P, Shaw J (2006) Metabolic syndrome: a new world-wide definition. A consensus statement from the International Diabetes Federation. Diabet Med 23:469–480PubMedCrossRef
12.
Zurück zum Zitat Grundy SM, Hansen B, Smith SC Jr, Cleeman JI et al (2004) Clinical management of metabolic syndrome: report of the American Heart Association/National Heart, Lung, and Blood Institute/American Diabetes Association conference on scientific issues related to management. Circulation 109:551–556PubMedCrossRef Grundy SM, Hansen B, Smith SC Jr, Cleeman JI et al (2004) Clinical management of metabolic syndrome: report of the American Heart Association/National Heart, Lung, and Blood Institute/American Diabetes Association conference on scientific issues related to management. Circulation 109:551–556PubMedCrossRef
13.
Zurück zum Zitat Jung CH, Hwang JY, Yu JH et al. (2012) The value of apolipoprotein B/A1 ratio in the diagnosis of metabolic syndrome in a Korean population. Clin Endocrinol (Oxf) [Epub ahead of print] Jung CH, Hwang JY, Yu JH et al. (2012) The value of apolipoprotein B/A1 ratio in the diagnosis of metabolic syndrome in a Korean population. Clin Endocrinol (Oxf) [Epub ahead of print]
14.
Zurück zum Zitat Koskinen J, Magnussen CG, Würtz P et al. (2011) Apolipoprotein B, oxidized low-density lipoprotein, and LDL particle size in predicting the incidence of metabolic syndrome: the cardiovascular risk in young finns study. Eur J Cardiovasc Prev Rehabil [Epub ahead of print] Koskinen J, Magnussen CG, Würtz P et al. (2011) Apolipoprotein B, oxidized low-density lipoprotein, and LDL particle size in predicting the incidence of metabolic syndrome: the cardiovascular risk in young finns study. Eur J Cardiovasc Prev Rehabil [Epub ahead of print]
15.
Zurück zum Zitat Eglit T, Rajasalu T, Lember M (2012) Metabolic syndrome in estonia: prevalence and associations with insulin resistance. Int J Endocrinol. Art ID: 951672 [Epub ahead of print] Eglit T, Rajasalu T, Lember M (2012) Metabolic syndrome in estonia: prevalence and associations with insulin resistance. Int J Endocrinol. Art ID: 951672 [Epub ahead of print]
16.
Zurück zum Zitat Mehta NN, Krishnamoorthy P, Martin SS et al (2011) Usefulness of insulin resistance estimation and the metabolic syndrome in predicting coronary atherosclerosis in type 2 diabetes mellitus. Am J Cardiol 107:406–411PubMedCrossRef Mehta NN, Krishnamoorthy P, Martin SS et al (2011) Usefulness of insulin resistance estimation and the metabolic syndrome in predicting coronary atherosclerosis in type 2 diabetes mellitus. Am J Cardiol 107:406–411PubMedCrossRef
18.
Zurück zum Zitat Wittchen HU, Balkau B, Massien C et al (2006) International day for the evaluation of abdominal obesity: rationale and design of a primary care study on the prevalence of abdominal obesity and associated factors in 63 countries. Eur Heart J 8(Suppl B):B26–B33CrossRef Wittchen HU, Balkau B, Massien C et al (2006) International day for the evaluation of abdominal obesity: rationale and design of a primary care study on the prevalence of abdominal obesity and associated factors in 63 countries. Eur Heart J 8(Suppl B):B26–B33CrossRef
19.
Zurück zum Zitat Li C, Ford ES, McGuire LC et al (2007) Increasing trends in waist circumference and abdominal obesity among US adults. Obesity (Silver Spring) 15:216–224CrossRef Li C, Ford ES, McGuire LC et al (2007) Increasing trends in waist circumference and abdominal obesity among US adults. Obesity (Silver Spring) 15:216–224CrossRef
20.
Zurück zum Zitat Canoy D, Boekholdt SM, Wareham N et al (2007) Body fat distribution and risk of coronary heart disease in men and women in the European prospective investigation into cancer and nutrition in norfolk cohort: a population-based prospective study. Circulation 116:2933–2943PubMedCrossRef Canoy D, Boekholdt SM, Wareham N et al (2007) Body fat distribution and risk of coronary heart disease in men and women in the European prospective investigation into cancer and nutrition in norfolk cohort: a population-based prospective study. Circulation 116:2933–2943PubMedCrossRef
21.
Zurück zum Zitat Fox KA, Després JP, Richard AJ et al (2009) Does abdominal obesity have a similar impact on cardiovascular disease and diabetes? A study of 91,246 ambulant patients in 27 European countries. Eur Heart J 30:3055–3063PubMedCrossRef Fox KA, Després JP, Richard AJ et al (2009) Does abdominal obesity have a similar impact on cardiovascular disease and diabetes? A study of 91,246 ambulant patients in 27 European countries. Eur Heart J 30:3055–3063PubMedCrossRef
22.
Zurück zum Zitat Lafortuna CL, Agosti F, De Col A et al (2012) Prevalence of the metabolic syndrome and its components among obese men and women in Italy. Obes Facts 5(1):127–137PubMedCrossRef Lafortuna CL, Agosti F, De Col A et al (2012) Prevalence of the metabolic syndrome and its components among obese men and women in Italy. Obes Facts 5(1):127–137PubMedCrossRef
23.
Zurück zum Zitat Wallace TM, Levy JC, Matthews DR (2004) Use and abuse of HOMA modeling. Diabetes Care 27:1487–1495PubMedCrossRef Wallace TM, Levy JC, Matthews DR (2004) Use and abuse of HOMA modeling. Diabetes Care 27:1487–1495PubMedCrossRef
24.
Zurück zum Zitat Wang JB, Zhang YJ, Zhang Y et al. (2010) Negative correlation between serum syndecan-1 and apolipoprotein A1 in patients with type 2 diabetes mellitus. Acta Diabetol [Epub ahead of print] Wang JB, Zhang YJ, Zhang Y et al. (2010) Negative correlation between serum syndecan-1 and apolipoprotein A1 in patients with type 2 diabetes mellitus. Acta Diabetol [Epub ahead of print]
25.
Zurück zum Zitat Williams K, Sniderman AD, Sattar N et al (2003) Comparison of the associations of apolipoprotein B and low-density lipoprotein cholesterol with other cardiovascular risk factors in the insulin resistance atherosclerosis study (IRAS). Circulation 108:2312–2316PubMedCrossRef Williams K, Sniderman AD, Sattar N et al (2003) Comparison of the associations of apolipoprotein B and low-density lipoprotein cholesterol with other cardiovascular risk factors in the insulin resistance atherosclerosis study (IRAS). Circulation 108:2312–2316PubMedCrossRef
26.
Zurück zum Zitat Sattar N, Williams K, Sniderman AD et al (2004) Comparison of the associations of apolipoprotein B and non-high-density lipoprotein cholesterol with other cardiovascular risk factors in patients with the metabolic syndrome in the insulin resistance atherosclerosis study. Circulation 110:2687–2693PubMedCrossRef Sattar N, Williams K, Sniderman AD et al (2004) Comparison of the associations of apolipoprotein B and non-high-density lipoprotein cholesterol with other cardiovascular risk factors in patients with the metabolic syndrome in the insulin resistance atherosclerosis study. Circulation 110:2687–2693PubMedCrossRef
27.
Zurück zum Zitat Ragogna F, Lattuada G, Ruotolo G et al (2012) Lack of association of apoE ε4 allele with insulin resistance. Acta Diabetol 49(1):25–32PubMedCrossRef Ragogna F, Lattuada G, Ruotolo G et al (2012) Lack of association of apoE ε4 allele with insulin resistance. Acta Diabetol 49(1):25–32PubMedCrossRef
28.
Zurück zum Zitat Walldius G, Jungner I (2005) Rationale for using apolipoprotein B and apolipoprotein A-I as indicators of cardiac risk and as targets for lipid-lowering therapy. Eur Heart J 26:210–212PubMedCrossRef Walldius G, Jungner I (2005) Rationale for using apolipoprotein B and apolipoprotein A-I as indicators of cardiac risk and as targets for lipid-lowering therapy. Eur Heart J 26:210–212PubMedCrossRef
29.
Zurück zum Zitat Walldius G, Jungner I, Holme I et al (2001) High apolipoprotein B, low apolipoprotein A-I, and improvement in the prediction of fatal myocardial infarction (AMORIS study): a prospective study. Lancet 358:2026–2033PubMedCrossRef Walldius G, Jungner I, Holme I et al (2001) High apolipoprotein B, low apolipoprotein A-I, and improvement in the prediction of fatal myocardial infarction (AMORIS study): a prospective study. Lancet 358:2026–2033PubMedCrossRef
30.
Zurück zum Zitat Holme I, Aastveit AH, Hammar N et al (2009) Lipoprotein components and risk of congestive heart failure in 84,740 men and women in the apolipoprotein mortality risk study (AMORIS). Eur J Heart Fail 11(11):1036–1042PubMedCrossRef Holme I, Aastveit AH, Hammar N et al (2009) Lipoprotein components and risk of congestive heart failure in 84,740 men and women in the apolipoprotein mortality risk study (AMORIS). Eur J Heart Fail 11(11):1036–1042PubMedCrossRef
31.
Zurück zum Zitat Jeppesen J, Hein HO, Suadicani P et al (1998) Triglyceride concentration and ischemic heart disease: an eight-year follow-up in the Copenhagen male study. Circulation 97:1029–1036PubMedCrossRef Jeppesen J, Hein HO, Suadicani P et al (1998) Triglyceride concentration and ischemic heart disease: an eight-year follow-up in the Copenhagen male study. Circulation 97:1029–1036PubMedCrossRef
32.
Zurück zum Zitat Walldius G, Aastveit AH, Jungner I (2006) Stroke mortality and the apoB/apoA-I ratio: results of the AMORIS prospective study. J Intern Med 259:259–266PubMedCrossRef Walldius G, Aastveit AH, Jungner I (2006) Stroke mortality and the apoB/apoA-I ratio: results of the AMORIS prospective study. J Intern Med 259:259–266PubMedCrossRef
33.
Zurück zum Zitat Schmidt C, Fagerberg B (2008) ApoB/apoA-I ratio is related to femoral artery plaques in 64-year-old women also in cases with low LDL cholesterol. Atherosclerosis 196:817–822PubMedCrossRef Schmidt C, Fagerberg B (2008) ApoB/apoA-I ratio is related to femoral artery plaques in 64-year-old women also in cases with low LDL cholesterol. Atherosclerosis 196:817–822PubMedCrossRef
34.
Zurück zum Zitat Bagry HS, Raghavendran S, Carli F (2008) Metabolic syndrome and insulin resistance: perioperative considerations. Anesthesiology 108:506–523PubMedCrossRef Bagry HS, Raghavendran S, Carli F (2008) Metabolic syndrome and insulin resistance: perioperative considerations. Anesthesiology 108:506–523PubMedCrossRef
35.
Zurück zum Zitat Sierra-Johnson J, Somers VK, Kuniyoshi FH et al (2006) Comparison of apolipoprotein-B/apolipoprotein-AI in subjects with versus without the metabolic syndrome. Am J Cardiol 98(10):1369–1373PubMedCrossRef Sierra-Johnson J, Somers VK, Kuniyoshi FH et al (2006) Comparison of apolipoprotein-B/apolipoprotein-AI in subjects with versus without the metabolic syndrome. Am J Cardiol 98(10):1369–1373PubMedCrossRef
36.
Zurück zum Zitat Belfki H, Ben Ali S, Bougatef S et al (2011) The Apolipoprotein B/Apolipoprotein A 1 ratio in relation to metabolic syndrome and its components in a sample of the Tunisian population. Exp Mol Pathol 91(2):622–625PubMedCrossRef Belfki H, Ben Ali S, Bougatef S et al (2011) The Apolipoprotein B/Apolipoprotein A 1 ratio in relation to metabolic syndrome and its components in a sample of the Tunisian population. Exp Mol Pathol 91(2):622–625PubMedCrossRef
37.
Zurück zum Zitat Festa A, D’Agostino R, Howard G et al (2000) Chronic subclinical inflammation as part of the insulin resistance syndrome: the insulin resistance atherosclerosis study (IRAS). Circulation 102:42–47PubMedCrossRef Festa A, D’Agostino R, Howard G et al (2000) Chronic subclinical inflammation as part of the insulin resistance syndrome: the insulin resistance atherosclerosis study (IRAS). Circulation 102:42–47PubMedCrossRef
Metadaten
Titel
Association of the apolipoprotein B/apolipoprotein A-I ratio and low-density lipoprotein cholesterol with insulin resistance in a Chinese population with abdominal obesity
verfasst von
Xin Ying
Yafang Qian
Yan Jiang
Zhenyan Jiang
Zhenya Song
Changjun Zhao
Publikationsdatum
01.12.2012
Verlag
Springer Milan
Erschienen in
Acta Diabetologica / Ausgabe 6/2012
Print ISSN: 0940-5429
Elektronische ISSN: 1432-5233
DOI
https://doi.org/10.1007/s00592-012-0419-9

Weitere Artikel der Ausgabe 6/2012

Acta Diabetologica 6/2012 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

29.05.2024 Larynxkarzinom Nachrichten

Fast ein Viertel der Personen mit mäßig dysplastischen Stimmlippenläsionen entwickelt einen Kehlkopftumor. Solche Personen benötigen daher eine besonders enge ärztliche Überwachung.

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

29.05.2024 Herzinfarkt Nachrichten

Bei Menschen mit Typ-2-Diabetes sind die Chancen, einen Myokardinfarkt zu überleben, in den letzten 15 Jahren deutlich gestiegen – nicht jedoch bei Betroffenen mit Typ 1.

15% bedauern gewählte Blasenkrebs-Therapie

29.05.2024 Urothelkarzinom Nachrichten

Ob Patienten und Patientinnen mit neu diagnostiziertem Blasenkrebs ein Jahr später Bedauern über die Therapieentscheidung empfinden, wird einer Studie aus England zufolge von der Radikalität und dem Erfolg des Eingriffs beeinflusst.

Costims – das nächste heiße Ding in der Krebstherapie?

28.05.2024 Onkologische Immuntherapie Nachrichten

„Kalte“ Tumoren werden heiß – CD28-kostimulatorische Antikörper sollen dies ermöglichen. Am besten könnten diese in Kombination mit BiTEs und Checkpointhemmern wirken. Erste klinische Studien laufen bereits.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.